Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial.
about
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trialsReview article: systemic and topical steroids in inflammatory bowel disease.Oral pH-modified release budesonide for treatment of inflammatory bowel disease, collagenous and lymphocytic colitis.Oral budesonide for the therapy of post-liver transplant de novo inflammatory bowel disease: a case series and systematic review of the literature.Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release model.
P2860
Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Replacement of conventional gl ...... rospective, multicenter trial.
@en
Replacement of conventional gl ...... rospective, multicenter trial.
@nl
type
label
Replacement of conventional gl ...... rospective, multicenter trial.
@en
Replacement of conventional gl ...... rospective, multicenter trial.
@nl
prefLabel
Replacement of conventional gl ...... rospective, multicenter trial.
@en
Replacement of conventional gl ...... rospective, multicenter trial.
@nl
P2093
P356
P1476
Replacement of conventional gl ...... rospective, multicenter trial.
@en
P2093
German/Austrian Budesonide Study Group
H J Schulz
J Schölmerich
P2888
P304
P356
10.1023/A:1021900115403
P577
2003-02-01T00:00:00Z
P6179
1044410729